Product name: TedizolidPhosphate

Alias: (R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-onedihydrogenphosphate;[(5R)-3- [3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyldihydrogenphosphate;TedizolidphosphateimpurityA;(R)- (3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyldihydrogenphosphate;(R)-3 -(4-(2-(2-methyl-tetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl-oxazolidin-2-onephosphate;(R)-3-(4-( 2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyloxazolidin-2-onephosphate;-3-(4-(2-(2-Methyltetrazol-5-yl)pyridine -5-yl)-3-fluorophenyl)-5-hydroxyMethyloxazolidin-2-onephosphate;(5R)-3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3 -pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone

CAS No.:856867-55-5

Molecular formula: C17H16FN6O6P

Molecular weight: 450.32

Structural formula:

TedizolidPhosphate (Tedizolidphosphate) is a second-generation oxazolidinone antibiotic developed by Dong-A Pharmaceutical. Its phase III clinical trial shows that its clinical effect is comparable to that of linezolid, and it has adverse reactions in the gastrointestinal tract and thrombocytopenia Less than linezolid, the incidence of drug resistance is also lower.